Not applicableNo Longer AvailableNCT00704925What this trial is testingTreatment of Lambert-Eaton Syndrome With 3,4 DAPWho this might be right forLambert Eaton Myasthenic Syndrome David P. Richman, MD
Not applicableEnrolling By InvitationNCT07072676What this trial is testingThe Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.Who this might be right forInclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more LMU Klinikum 30
Not applicableNo Longer AvailableNCT01373333What this trial is testingUse Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic SyndromeWho this might be right forLambert-Eaton Myasthenic Syndrome The Cleveland Clinic
Large-scale testing (Phase 3)Study completedNCT02970162What this trial is testingPhase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)Who this might be right forLambert-Eaton Myasthenic Syndrome Catalyst Pharmaceuticals, Inc. 26
Early research (Phase 1)Study completedNCT07105371What this trial is testingPatients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome SolutionWho this might be right forMotor Disorders The Foundation for Orthopaedics and Regenerative Medicine 18
Early research (Phase 1)Study completedNCT01203592What this trial is testingEfficacy of Albuterol in the Treatment of Congenital Myasthenic SyndromesWho this might be right forCongenital Myasthenic Syndrome Mayo Clinic 21
Not applicableUnknownNCT02124616What this trial is testingNational Registry for Egyptian Pediatric Neuromuscular DiseasesWho this might be right forSpinal Muscular AtrophyMuscular DystrophyMuscle Diseases+2 more Ain Shams University 200
Not applicableEnrolling By InvitationNCT06605612What this trial is testingDevelopment and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular DisordersWho this might be right forInclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more LMU Klinikum 108
Not applicableLooking for participantsNCT07136844What this trial is testingGait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic PathologyWho this might be right forNeuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more Centre Hospitalier Universitaire de Liege 300
Early research (Phase 1)Looking for participantsNCT06436742What this trial is testingA Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)Who this might be right forCongenital Myasthenic SyndromeCMS argenx 16
Not applicableApproved For MarketingNCT00872950What this trial is testing3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)Who this might be right forLambert-Eaton Myasthenic SyndromeCongenital Myasthenic Syndrome Lahey Clinic
Not applicableLooking for participantsNCT07478172What this trial is testingEffects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular DiseaseWho this might be right forNeuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more University of Missouri-Columbia 50
Not applicableStudy completedNCT01474980What this trial is testingPregnancy Outcomes in Congenital Myasthenie SyndromeWho this might be right forCongenital Myasthenic Syndrome Institut de Myologie, France 25
Not applicableStudy completedNCT00004832What this trial is testingRandomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic SyndromeWho this might be right forLambert-Eaton Myasthenic Syndrome FDA Office of Orphan Products Development 26
Not applicableLooking for participantsNCT06078553What this trial is testingA Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4Who this might be right forCongenital Myasthenic Syndrome argenx 100
Not applicableNo Longer AvailableNCT03062631What this trial is testingTreatment Use of 3,4 Diaminopyridine in Congenital MyastheniaWho this might be right forCongenital Myasthenic Syndrome Ricardo Maselli
Not applicableLooking for participantsNCT01403402What this trial is testingCongenital Muscle Disease Study of Patient and Family Reported Medical InformationWho this might be right forCongenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) DeficiencyAlpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations)+49 more Cure CMD
Not applicableNo Longer AvailableNCT00994916What this trial is testingTreatment of Lambert-Eaton Syndrome With 3,4 DiaminopyridineWho this might be right forLambert-Eaton Myasthenic Syndrome David Lacomis, MD
Not applicableLooking for participantsNCT06630650What this trial is testingA Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic SyndromesWho this might be right forMyasthenic Syndromes, Congenital National Institute of Neurological Disorders and Stroke (NINDS) 75
Not applicableNot Yet RecruitingNCT07075627What this trial is testingEvaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)Who this might be right forSmall Cell Lung Cancer ( SCLC )Lambert Eaton Myasthenic Syndrome (LEMS) Addario Lung Cancer Medical Institute 400